Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.

Launch Date: February 4, 2025

Release Date: February 4, 2025

Expiration Date: January 31, 2026

FACULTY

Jonathan C. Roberts, MD

Associate Medical Director

Associate Research Director

Bleeding and Clotting Disorders Institute

Associate Professor of Pediatrics and Medicine

University of Illinois College of Medicine at Peoria

Mindy Simpson, MD

Medical Director

Rush Hemophilia and Thrombophilia Center

Assistant Professor of Pediatrics in Pediatric Hematology/Oncology

Rush University Medical Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.